Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule

Publications

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

2008

Becerra SP, Perez-Mediavilla LA, Weldon JE, Senanayake P, Notari L, Notario V, Hollyfield JG. 2008. Pigment epithelium-derived factor (PEDF) binds to hyaluronan: mapping of a hyaluronan binding site. J Biol Chem 283(48):33310-20.

Belle, I., L. Hou, M. Chen, N.K. Steiner, J. Ng, C.K. Hurley. 2008. Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DLS1 in a transplant population. Tissue Antigens 71:434-9.

Coticchia, CM, Revankar, C. M., Deb, T. B., Dickson, R. B., and Johnson, M. D. Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat 2008; Epub ahead of print

Endo, Y, Deonauth, K., Prahalad, P., Hoxter, B., Zhu, Y., and Byers, S. W. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS ONE 2008;3:e2714

Fishbein T, Novitskiy G, Mishra L, Matsumoto C, Kaufman S, Goyal S, Shetty K, Johnson L, Lu A, Wang A, Hu F, Kallakury B, Lough D, Zasloff M. 2008. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 57(3):323-330.

Foshay K, Gallicano GI. 2008. Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells and Development 17(2):269-78.

Hou, L., N.K. Steiner, M. Chen, I. Belle, A.L. Kubit, J. Ng, C.K. Hurley. 2008. Limited allelic diversity of stimulatory two domain killer immunoglobulin-like receptors. Human Immunology 69:174-178.

Hwang SH, Rait A, Pirollo KF, Zhou Q, Yenugonda VM, Chinigo GM, Brown ML, Chang EH. 2008. Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue 2. Mol Cancer Ther 7(3):559-568.

Jiao X, Katiyar S, Liu M, Mueller SC, Lisanti MP, Li A, Pestell TG, Wu K, Ju X, Li Z, Wagner EF, Takeya T, Wang C, Pestell RG. 2008. Disruption of c-Jun Reduces Cellular Migration and Invasion through Inhibition of c-Src and Hyperactivation of ROCK II Kinase. Mol Biol Cell 19(4):1378-1390.

Jones, LP, Tilli, M. T., Assefnia, S., Torre, K., Halama, E. D., Parrish, A., Rosen, E. M., and Furth, P. A. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene 2008;27:794-802.

Kang HJ, Kim HJ, Kwon SH, Kang BD, Eling TE, Lee SH, Bae I. 2008. BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity. Cancer Chemother Pharmacol 62:689-697.

Kim DC, Ramachandran S, Baek SH, Kwon SH, Kwon KY, Cha SD, Bae I, Cho CH. 2008. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod Sci 15(6):552-558.

Mulrooney, T.J., L. Hou, N.K. Steiner, M. Chen,I. Belle, J. Ng, C.K. Hurley. 2008. Promoter variants of KIR2DL5 add to diversity and may impact gene expression. Immunogenetics 60:287-94.

Oh, AS, Lahusen, J. T., Chien, C. D., Fereshteh, M. P., Zhang, X., Dakshanamurthy, S., Xu, J., Kagan, B. L., Wellstein, A., and Riegel, A. T. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Mol Cell Biol 2008; Epub ahead of print

Olivo S, Zhu Y, Lee RY, Khan G, Zwart A, Wang Y, Clarke R, Hilakivi-Clarke L. 2008. Identification of gene signaling pathways mediating the breast cancer risk reducing effects of prepubertal dietary exposure to low fat n-3 polyunsaturated fatty acids. Cancer Prevention Research 1(7):532-45.

Pirollo KF, Rait A, Zhou Q, Zhang XQ, Zhou J, Kim CS, Benedict WF, Chang EH. 2008. Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo. Clin Cancer Res 14(7):2190-2198.

Riggins RB, Lan JP, Klimach U, Zwart A, Cavalli LR, Haddad BR, Chen L, Gong T, Xuan J, Ethier SP, Clarke R. 2008. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 68(21):8908-8917.

Sikora MJ, Cordero KE, Larios JM, Johnson MD, Lippman ME, Rae JM. 2008. The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. Breast Cancer Res Treat Epub ahead of print.

Steiner, N.K., S. Dakshanamurthy, C.J. Vandenbussche, C.K. Hurley. 2008. Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5. Immunogenetics 60(11):655-667.

Thibodeaux, CA, Liu, X., Disbrow, G. L., Zhang, Y., Rone, J. D., Haddad, B. R., and Schlegel, R. Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant. 2008. Breast Cancer Res Treat Epub ahead of print

Tirado OM, Mateo-Lozano S, Villar J, Notario V. 2008. Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells. Int J Cancer 12(22):6781-90.

Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, Lee MS, Wang JK, Sloane DE, Johnson M, Lin CY. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am J Physiol Cell Physiol 2008; 295(2):C423-C431.

VandenBussche, C.J., T.J. Mulrooney, W.R. Frazier, S. Dakshanamurthy, C.K. Hurley. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immunity, 2009 Mar;10(2):162-73. Epub 2008 Nov 13.

[Veselik DJ, Divekar S, Dakshanamurthy S, Storchan GB, Turner JM, Graham KL, Huang L, Stoica A, Martin MB. 2008. Activation of estrogen receptor-alpha by the anion nitrite. Cancer Res 68(10):3950-3958.

Wang M, Yu B, Westerlind K, Strange R, Khan G, Patil D, Boeneman K, Hilakivi-Clarke L. 2008. Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland. Breast Cancer Res Treat [Epub ahead of print]

Wang T, Simbulan-Rosenthal CM, Smulson ME, Chock PB, Yang DC. Polyubiquitylation of PARP-1 through ubiquitin K48 is modulated by activated DNA, NAD(+), and dipeptides. J Cell Biochem 2008; 104:318-328.

Yang C, Rait A, Pirollo KF, Dagata JA, Farkas N, Chang EH. 2008. Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo. Nanomedicine 4(4):318-29.

Yu H, Gong X, Luo X, Han W, Hong G, Singh B, Tang CK. 2008. Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways. Cancer Biol Ther 7(11). [Epub ahead of print]